Preclinical Assessment of a New Hybrid Compound C11 Efficacy on Neurogenesis and Cognitive Functions after Pilocarpine Induced Status Epilepticus in Mice.

MLA

Andres-Mach, Marta, et al. “Preclinical Assessment of a New Hybrid Compound C11 Efficacy on Neurogenesis and Cognitive Functions after Pilocarpine Induced Status Epilepticus in Mice.” International Journal of Molecular Sciences, vol. 22, no. 6, Mar. 2021. EBSCOhost, https://doi.org/10.3390/ijms22063240.

APA

Andres-Mach, M., Szewczyk, A., Zagaja, M., Szala-Rycaj, J., Lemieszek, M. K., Maj, M., Abram, M., & Kaminski, K. (2021). Preclinical Assessment of a New Hybrid Compound C11 Efficacy on Neurogenesis and Cognitive Functions after Pilocarpine Induced Status Epilepticus in Mice. International Journal of Molecular Sciences, 22(6). https://doi.org/10.3390/ijms22063240

Chicago

Andres-Mach, Marta, Aleksandra Szewczyk, Mirosław Zagaja, Joanna Szala-Rycaj, Marta Kinga Lemieszek, Maciej Maj, Michał Abram, and Krzysztof Kaminski. 2021. “Preclinical Assessment of a New Hybrid Compound C11 Efficacy on Neurogenesis and Cognitive Functions after Pilocarpine Induced Status Epilepticus in Mice.” International Journal of Molecular Sciences 22 (6). doi:10.3390/ijms22063240.